Literature DB >> 30573695

New short regimens for latent tuberculosis treatment: safety first!

Dick Menzies1, Anete Trajman2,3.   

Abstract

Entities:  

Year:  2018        PMID： 30573695     DOI： 10.1183/13993003.02180-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

Review 1.  Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review.

Authors:  Noor Ul Ain Shahid; Noreen Naguit; Rakesh Jakkoju; Sadia Laeeq; Tiba Reghefaoui; Hafsa Zahoor; Ji Hyun Yook; Muneeba Rizwan; Lubna Mohammed
Journal:  Cureus       Date:  2022-05-17

Review 2.  Latent tuberculosis infection in patients with rheumatic diseases.

Authors:  Camila Anton; Felipe Dominguez Machado; Jorge Mario Ahumada Ramirez; Rafaela Manzoni Bernardi; Penélope Esther Palominos; Claiton Viegas Brenol; Fernanda Carvalho de Queiroz Mello; Denise Rossato Silva
Journal:  J Bras Pneumol       Date:  2019-04-25       Impact factor: 2.624
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.